Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–1092.
   PubMed Web of Science ®Google Scholar
• Ahadi A, Brennan S, Kennedy PJ, et al. Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes. Sci Rep. 2016;6:24922.
   PubMed Web of Science ®Google Scholar
• Xu M, Xu X, Pan B, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18:135.
   PubMed Web of Science ®Google Scholar
• Pan JC, Meng XD, Gong ZH. The role of lncRNA as competitive endogenous RNA in non-small cell lung cancers. Prog Biochem Biophys. 2018;45:1126–1135.
   Web of Science ®Google Scholar
• Hou C, Wang X, Du B. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p. Exp Ther Med. 2020;20:978–984.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao SM, Xu C, et al. Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis. Biochem Biophys Res Commun. 2020;533:429–436.
   PubMed Web of Science ®Google Scholar
• Yao CL, Cheng XH, Guo XQ, et al. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis. Cancer Cell Int. 2020;20:11.
   PubMed Web of Science ®Google Scholar
• Huo W, Qi F, Wang KC. Long non-coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11. Oncol Rep. 2020;44:1233–1245.
   PubMed Web of Science ®Google Scholar
• Zhou YJ, Yang HQ, Xia W, et al. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. J Biochem. 2020;167:295–301.
   PubMed Web of Science ®Google Scholar
• Cao G, Tan B, Wei SZ, et al. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p. Biomed Pharmacother. 2020;125:7.
   Web of Science ®Google Scholar
• Wei XS, Yang XM, Wang BB, et al. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer. Cancer Med. 2020;9:724–736.
   PubMed Web of Science ®Google Scholar
• Han G, Qiu N, Luo K, et al. Downregulation of miroRNA-141 mediates acquired resistance to trastuzumab and is associated with poor outcome in breast cancer by upregulating the expression of ERBB4. J Cell Biochem. 2019;120(7):11390–11400.
   Web of Science ®Google Scholar
• Yu FQ, Wang Z, Wang XW, et al. MicroRNA-885-5p promotes osteosarcoma proliferation and migration by downregulation of cell division cycle protein 73 homolog expression. Oncol Lett. 2019;17:1565–1572.
   PubMed Web of Science ®Google Scholar
• Ye Y, Li SL, Wang JJ. miR-100-5p downregulates mTOR to suppress the proliferation, migration, and invasion of prostate cancer cells. Front Oncol. 2020;10:11.
   PubMed Web of Science ®Google Scholar
• Tian JH, Zhang HB, Mu LJ, et al. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3 beta pathway in prostate cancer. Exp Cell Res. 2020;394:9.
   Web of Science ®Google Scholar
• Huang Q, Ma B, Su YX, et al. miR-197-3p represses the proliferation of prostate cancer by regulating the VDAC1/AKT/beta-catenin signaling axis. Int J Biol Sci. 2020;16:1417–1426.
   PubMed Web of Science ®Google Scholar
• Zhiping C, Shijun T, Linhui W, et al. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2. Eur Rev Med Pharmacol Sci. 2017;21:4835–4843.
   PubMed Web of Science ®Google Scholar
• Shen H, Weng XD, Liu XH, et al. miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer. Int J Clin Exp Pathol. 2018;11:3969–3976.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Yeh IJ, Liu KT, Shen JH, et al. Identification of the potential prognostic markers from the miRNA-lncRNA-mRNA interactions for metastatic renal cancer via next-generation sequencing and bioinformatics. Diagnostics (Basel). 2020;10. DOI:10.3390/diagnostics10040228.
   Google Scholar
• Xu HY, Wang LY, Jiang XL. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis. Mol Cell Biochem. 2020;476:1051-1061.
   Web of Science ®Google Scholar
• Du LJ, Mao LJ, Jing RJ. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway. Biochem Biophys Res Commun. 2020;533:565–572.
   PubMed Web of Science ®Google Scholar
• Li XF, Wang ZQ, Li LY, et al. Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane- pretreated mice against ischemia-reperfusion injury by targeting KCNMA1. Exp Mol Med. 2018;50:16.
   PubMed Web of Science ®Google Scholar
• Li P, Xing W, Xu J, et al. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer. Stem Cell Res Ther. 2019;10:144.
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang Y, Liu L, et al. Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p. Clin Res Hepatol Gastroenterol. 2020;44:101–114.
   PubMed Web of Science ®Google Scholar
• Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhao X, Wang H, et al. The down-regulation of lncRNA PCAT18 promotes the progression of gastric cancer via MiR-107/PTEN/PI3K/AKT signaling pathway. Onco Targets Ther. 2019;12:11017–11031.
   PubMed Web of Science ®Google Scholar
• Wu K, Mu XY, Jiang JT, et al. miRNA26a5p and miR26b5p inhibit the proliferation of bladder cancer cells by regulating PDCD10. Oncol Rep. 2018;40:3523–3532.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen G, He J, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;12:325–340.
   PubMed Web of Science ®Google Scholar
• Sun YB, Jiang TX, Jia YQ, et al. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway. Cell Cycle. 2019;18:2509–2523.
   PubMed Web of Science ®Google Scholar
• Yu J, Jiang LJ, Gao YT, et al. LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration. Exp Ther Med. 2019;17:4259–4266.
   PubMed Web of Science ®Google Scholar
• Yu C, Sun JX, Leng XG, et al. Long noncoding RNA SNHG6 functions as a competing endogenous RNA by sponging miR-181a-5p to regulate E2F5 expression in colorectal cancer. Cancer Manag Res. 2019;11:611–624.
   PubMed Web of Science ®Google Scholar
• Hu W, Yan FQ, Ru Y, et al. MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a/b-5p-KLF17 axis. Am J Cancer Res. 2020;10:630.
   PubMed Web of Science ®Google Scholar
• Chang S, Chen B, Wang X, et al. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC Cancer. 2017;17:248.
   PubMed Web of Science ®Google Scholar
• Lozano-Bartolome J, Llaurado G, Portero-Otin M, et al. Altered expression of miR-181a-5p and miR-23a-3p is associated with obesity and TNFalpha-Induced insulin resistance. J Clin Endocrinol Metab. 2018;103:1447–1458.
   PubMed Web of Science ®Google Scholar
• Dastmalchi N, Hosseinpourfeizi MA, Khojasteh SMB, et al. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sci. 2020;259:13.
   Web of Science ®Google Scholar
• Bi XH, Lv X, Liu DJ, et al. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Cancer Gene Ther. 2020;15
   Google Scholar
• Zhang X, Wang DW, Liu BK, et al. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. J Exp Clin Cancer Res. 2020;39:12.
   PubMed Web of Science ®Google Scholar